ACTINIUM AC-225 ALPITATUG SATETRAXETAN
UNII DP81KW1394

Substance Identification & Data

This profile provides standardized clinical and technical data for Actinium Ac-225 Alpitatug Satetraxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DP81KW1394.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2921676-06-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DP81KW1394

CAS Registry Number

2921676-06-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ACTINIUM AC-225 ALPITATUG SATETRAXETAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211713

National Cancer Institute reference terminology for clinical and research data.

INN ID

13164

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-149

Identifier assigned by the United States Adopted Names Council.

Substance Type

Actinium Ac-225 Alpitatug Satetraxetan

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Actinium Ac-225 Alpitatug Satetraxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Actinium (225 Ac) Alpitatug Satetraxetan

Actinium Ac-225 Alpitatug Satetraxetan

Common Names & Synonyms

ACTINIUM AC 225 ALPITATUG SATETRAXETAN [USAN]

Actinium Alpitatug Satetraxetan Ac-225

Alpitatug Satetraxetan Actinium Ac-225

Immunoglobulin G1, anti-(human kallikrein 2) (human-Mus musculus monoclonal KL2B1 allotype G1m(17) γ1-chain), disulfide with human-Mus musculus monoclonal KL2B1 κ-chain, dimer, N6-[[[4-[[1,4,7,10-tetrakis[(carboxy-κO)methyl]-1,4,7,10-tetr...

Immunoglobulin G1-kappa, anti-[Homo sapiens KLK2 (kallikrein-2, kallikrein peptidase 2, kallikrein 2 prostatic)], humanized monoclonal antibody; H-gamma1 heavy chain humanized (1-447) [VH (Homo sapiens IGHV4-28*01 (90.7%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT [9.7.10] (26-34.52-58.97-106)) (1-117) -Homo sapiens IGHG1*03v (100%) G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14 (CH1 R120>K (214) (118-215), hinge 1-15 (216-230), CH2 (231-340), CH3 E12 (356), M14 (358) (341-445), CHS (446-447)) (118-447)], (220-218')-disulfide with L-kappa light chain humanized (1'-218') [V-KAPPA (Homo sapiens IGKV4-1*01 (81.2%) -IGKJ2*01 (100%), CDR-IMGT [10.3.9] (27'-36'.54'-56'.93'-101')) (1'-111') - Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (157'), V101 (195')) (112'-218')]; dimer (226-226'':229-229'')- bisdisulfide, produced in Chinese hamster ovary (CHO) cells, glycoform alfa; conjugated via the side chain nitrogen of an average of 3 lysine residues to actinium (225Ac) radiolabeled rac-(4-{[(2R)-1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecan-2-yl]methyl}phenyl)carbamothioyl (satetraxetan)

actinium (225 Ac) alpitatug satetraxetan [INN]